Andrew Levin is Board Director on GentiBio Board of Directors. Andrew is a Managing Director and co-leads the Venture Team at RA Capital Management, a healthcare and life sciences focused investment firm. Prior to joining RA, he was a Vice President at H.I.G. BioVentures and served as the Director of Pharmaceutical Sciences at the Clinton Health Access Initiative. He received a BSE in Mechanical Engineering from Princeton University, a PhD. in Biomedical Engineering from the Massachusetts Institute of Technology, and an MD from Harvard Medical School.
Andrew Levin, MD, PhD
Managing Director, RA Capital Management, Board Director